New data from the CDC reveal that opioid overdose deaths have decreased to their lowest since 2020.
Opioid overdoses are leading to less deaths compared with the beginning of 2024, according to new data released by the CDC compiling data on deaths due to opioid overdose.1 Another decrease in deaths related to opioids in the past month makes it 12 consecutive months of decreasing deaths and the lowest number of deaths since 2020.
The reported number of predicted deaths linked to opioids was 70,655 through June 2024, which is lower than the number in June 2023, when the predicted number was 86,401. Overdose death rates are also decreasing in all but a few states, including Alaska, whose reported deaths increased from 219 to 339 from June 2023 to June 2024. Similar trends are found in Nevada, where the reported deaths increased from 814 to 997; Oregon, where reported deaths increased from 1248 to 1366; and Washington, where reported deaths increased from 2619 to 2763.
This trend of decreasing deaths comes after the CDC reported more than 1 million people in the United States had died of drug overdoses from 1990, with the majority of them being related to opioids, such as fentanyl.2 The economic cost of the opioid crisis has surpassed $1 trillion as solutions to patient addiction have been at the forefront of health care policy.
Deaths due to opioid overdose have decreased for the 12th consecutive month | Image credit: Victor Moussa - stock.adobe.com
There are several factors that could be contributing to this decrease in deaths related to opioid overdoses, including the overdose-reversing spray naloxone becoming more broadly available. The FDA approved the use of naloxone nasal spray for OTC use in March 2023,3 which enhanced accessibility for those who needed it the most and reduced the barrier of a prescription to get care needed in emergency overdosing situations. High school students are also reporting lower rates of illegal drug use.4 However, some demographic populations still have higher rates of death due to opioids, making targeted interventions in those demographics vital in decreasing overall deaths.
Another factor that could be affecting deaths due to opioids is a shift in illegal drug supply, according to CBS News.4 This can include the rise of xylazine making injection drug use less appealing and also reducing the number of times that drugs are used per day due to its elongated effects. Xylazine is traditionally used in veterinary practices, which is what it was approved for by the FDA in 1972.5 Its increased use could portent a different driver of drug overdoses in the future.
Overall, the decreased number of deaths due to opioid overdose is a positive sign that different methods of combatting overdoses, such as naloxone availability, seem to be helping in mitigating the widespread effects of the opioid epidemic. However, more work needs to be done, specifically in the Native American population and among Black men, to continue to push the number down, as the deaths are still numbering more than 50,000 per year. Finding the root of the reasons the numbers are decreasing and employing safe methods of decreasing opioid use in demographics on the higher end of the spectrum should be the biggest priorities moving forward, experts say.
References
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias
July 30th 2025Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the importance of food assistance in combating Alzheimer disease and dementia risks.
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More